ReviewImmunoTargets and therapy2020

Time to Develop Therapeutic Antibodies Against Harmless Proteins Colluding with Sepsis Mediators?

Jianhua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.